scholarly journals Portrayal of Sickle Cell Disease Complications By Commercial Question Banks

Blood ◽  
2021 ◽  
Vol 138 (Supplement 1) ◽  
pp. 4938-4938
Author(s):  
Paige Reilly ◽  
Alexis Rodriguez ◽  
Cristiana Hentea

Abstract BACKGROUND Sickle cell disease (SCD) affects ~100,000 people in the US and is associated with multi-system acute and chronic complications that shorten lifespan. While most pediatric patients in the US survive beyond age 18, the risk of death increases dramatically during late adolescence and young adulthood. This surge is due partly to insufficient access to comprehensive sickle cell and subspecialty care. As a result, patients with episodic SCD care have high rates of ED use and hospitalization, incurring substantial cost. Emergency physicians, hospitalists, and primary care physicians are frequently responsible for these highly complex patients and studies suggest that they lack necessary SCD knowledge and training. Question banks have emerged as the most widely used educational resource among medical students and residents studying for licensing exams. Medical trainees favor question banks over all other learning platforms, including lecture, to learn new material and for review. Question banks feature "highest-yield" topics and may be viewed as the most important clinical knowledge to carry into practice. Our study aims to examine SCD-related content in the most popular commercial question bank to determine how this important teaching platform serves to educate medical trainees about the complex pathophysiology and scope of SCD. METHODS We obtained access to three question banks used by trainees to prepare for the current USMLE Step 1, Step 2, and Step 3 exams. The keyword "sickle cell" was entered into a search feature. Inclusion criteria consisted of question vignettes that included a patient with SCD. Exclusion criteria comprised questions featuring patients with sickle cell trait or other hemoglobinopathy and non-SCD questions with SCD-related answer choices. Resulting questions were analyzed for disease-related topic and patient age. Questions were assigned to one of the following categories, selected due to high incidence of clinically significant complications per NHLBI guidelines: vasooclusive crisis (VOC)/pain, fever/infection, stroke, acute chest syndrome (ACS), spleen, renal, priapism, or hepatobiliary. Questions outside of these categories were designated "other." Patient age was categorized by group: birth to 5 years, 6-10 years, 11-15 years, 16-20 years, and 20 years or older. For clinical vignettes with multiple questions in series, questions were categorized individually while the patient was counted once (ex: 5-year-old with VOC in first question, develops ACS in second question: one "VOC/pain," one "ACS," and one patient 0-5 years). Test questions that were unrelated to the clinical vignette were categorized by the patient's clinical history (ex: 12-year-old frequently hospitalized for pain and observed sickle-shaped RBCs on peripheral smear most likely has what sequence in the beta-globin gene? Categorized as "VOC/pain" and patient 11-15 years). RESULTS There were 9041 questions total in the three banks. "Hematology & Oncology" questions comprised 5.3% (478/9041) of content and less than 1% were tagged "sickle cell" (0.55%, 50/9041). However, SCD rarely formed the question content (0.24%, 22/9041). A total of 20 patients with SCD were presented in questions. Pediatric patients were featured in almost every question (90.0%, 18/20) and the median patient age was 7.5 years. Two questions involved adult patients (M, F; age 23) and both presented to the ER with pain. Acute VOC pain, including dactylitis, was the most common complaint (36.4%, 8/22), followed by patients with fever or infection (27.3%, 6/22). Acute chest syndrome and splenic dysfunction (from fibrosis) were each tested once and acute stroke was tested twice (Table 1). There were no questions about renal failure, priapism, hepatobiliary complications, or splenic sequestration. CONCLUSIONS Our study found a significant proportion of questions focused on acute SCD pain in pediatric patients. Adult SCD patients were largely omitted from this question bank's content. Given that medical trainees favor question banks over all other learning platforms, this finding may suggest a limited scope of understanding of this disease. Figure 1 Figure 1. Disclosures No relevant conflicts of interest to declare.

2016 ◽  
Vol 23 (8) ◽  
pp. 932-940 ◽  
Author(s):  
Dina D. Daswani ◽  
Vaishali P. Shah ◽  
Jeffrey R. Avner ◽  
Deepa G. Manwani ◽  
Jessica Kurian ◽  
...  

Blood ◽  
2014 ◽  
Vol 124 (21) ◽  
pp. 4838-4838
Author(s):  
Sophia Sharifali ◽  
Lashon Sturgis ◽  
Cindy Neunert ◽  
Natalie Lane ◽  
Robert Gibson ◽  
...  

Abstract Acute vaso-occlusive crisis (VOC), the most common manifestation of Sickle Cell Disease (SCD), is the number one cause for visits to the Emergency Department (ED). Pediatric patients differ from adult patients with SCD due to variations in opioid tolerance and age-specific complications. Many pediatric patients can be sent home after evaluation and treatment in an ED, however, others will need hospitalization for further pain management as well as continued evaluation. Observation Units (OUs), ED-associated units for evaluation and protocol management of short-term conditions (<24 hours), have successfully provided more rapid care while still maintaining quality. At our institution, using an OU-based protocol, we have demonstrated improved care with decreased resource utilization in an adult population with SCD experiencing VOC. However, there is limited data for the use of OU in pediatric patients with VOC. Our objective was to determine the feasibility of a pediatric OU for the evaluation and treatment of patients with uncomplicated VOC. A retrospective, descriptive chart review study was conducted on all pediatric patients (<18 years) with SCD between July 1, 2012 to June 30, 2013. The study was conducted in an academic pediatric tertiary care hospital (annual volume 27k/year). A medical record search was conducted using ICD-9 codes and SCD related DRG codes. The cohort was then limited to patients who received care in the academic ED or were transferred from another hospital for direct admission (DA). The cohort was limited to visits with pain related to VOC. Patients with a complication other than VOC were excluded as well as patients admitted to the intensive care unit. Cohort data as well as exclusion criteria are in table 1. Visits that were admitted to the floor (either as a direct admission or admitted from the ED) with a length of stay (LOS) less than 48 hours were included in the analysis. Patients were grouped into categories based on LOS: < 24 hours, <36 hours, and <48 hours Though the OU will only manage up to 24 hours, categories of LOS longer than 24 hours were included in order to capture elements that may lengthen a patients stay such as waiting time, time until disposition and discharge. Table 1. Sample Size and Exclusion Criteria # of Patients treated for Sickle Cell Between 7/1/2012 - 6/30,2012 197 patients Limiting to patients seen in ED or having a DA 119 patients Limiting to confirmed diagnosis of SCD (multiple genotypes) = 6 113 patients Limiting to reason of visit to a pain complaint = 6 107 patients Limiting to reason of pain to VOC = 3 104 patients Limited or no data in EMR (left prior to treatment) = 3 101 patients Exclusion of patients with visits only for complications of SCD* = 21 80 patients Final Sample Size for analysis 80 patients *Complications include acute chest syndrome, sepsis, splenic sequestration, fever, infiltrates, and infection 80 patients had 160 visits for uncomplicated VOC from 7/1/2012 - 6/30/2012. Of the 160 visits, the patient was admitted53.8% (86) of the time. Of the 86 visits resulting in admission, 30 (34.9%) were DA and 56 (65.1%) were admitted from the academic ED. LOS of the admission by DA or from the academic ED is in table 2. Table 2. LOS for Admissions DA to Floor 30 total visits LOS < 24 Hours 5 (16.6%) visits LOS < 36 Hours 10 (33.3%) visits LOS < 48 Hours 17 (56.7%) visits ED to Floor 56 total visits LOS < 24 Hours 4 (7.1%) visits LOS < 36 Hours 10 (17.9%) visits LOS < 48 Hours 21 (37.5%) visits OU's are ideal for the evaluation and management of patients requiring more than a few hours of ED treatment but less than 24 hours of hospital therapy. Our study shows that there is a large number of patients with SCD and VOC are admitted (53.8%). Based on our study, 44% of admissions have a LOS less than 48 hours. We believe that 48 hours is a reasonable cutoff for consideration of OU care as disposition decisions on the floor occur at 12-hour and sometimes 24-hour intervals leading to an increase in LOS beyond the actual treatment time. All patients, including DA patients, should be eligible for OU treatment if they meet inclusion criteria. This is evidenced by the finding that the LOS is shorter for DA patients (56.7%) versus admissions from the academic ED (37.5%). Overall, pediatric SCD patients would benefit from the presence of a pediatric OU by potentially decreasing the rate of inpatient admissions. An observation unit should therefore be strongly considered in centers with large volume SCD. Disclosures No relevant conflicts of interest to declare.


Sign in / Sign up

Export Citation Format

Share Document